Japan economic and financial daily Nihon KeizaiShimbun yesterday reported that Takeda Pharmaceutical is about to divest assets for $10bn in order to offset the debt–which has reached $48bn now–built up by acquiring Shire for $62bn.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,